Uso de fármacos dopaminérgicos en el síndrome SILENT: caso clínico y revisión de la literatura
Date
2023-10Permanent link
https://hdl.handle.net/11351/12599DOI
10.60940/PsicosomPsiquiatrnum270904
ISSN
2565-0564
Abstract
Lithium is considered the standard mood stabilizer used in the treatment and prevention of bipolar disorder. However, it is not free from side effects. Neurotoxicity is one of them and can persist even after withdrawal of the drug. This entity is known as Lithium-Induced Irreversible Neurotoxicity Syndrome (SILENT).
Keywords
Lithium toxicity; Silent syndrome; Bipolar disorderBibliographic citation
Nieto Campaña A, Martin Pérez M, Fors Clapés I, Ferrer Ferran I. Uso de fármacos dopaminérgicos en el síndrome SILENT: caso clínico y revisión de la literatura. Sessió de pòster presentat a: VI Simposio de psicosomática y psiquiatría; 2023 Oct 27; Barcelona.
Audience
Professionals
This item appears in following collections
The following license files are associated with this item:




